Works matching IS 17562856 AND DT 2014 AND VI 7 AND IP 6
Results: 4
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 6, p. 289, doi. 10.1177/1756285614556287
- By:
- Publication type:
- Article
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 6, p. 263, doi. 10.1177/1756285614555335
- By:
- Publication type:
- Article
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 6, p. 279, doi. 10.1177/1756285614549554
- By:
- Publication type:
- Article
High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case report.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 6, p. 276, doi. 10.1177/1756285614548189
- By:
- Publication type:
- Article